header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-19353
Fish name: tdgf1tz257/tz257
Genotype: tdgf1tz257/tz257
Targeting Reagent: none
HUMAN DISEASE MODELED by tdgf1tz257/tz257
No data available
GENE EXPRESSION
Gene expression in tdgf1tz257/tz257
RNA expression
Expressed Gene Structure Conditions Figures
bmp2b standard conditions Fig. S11 with image from Xiong et al., 2006
camsap2a standard conditions Fig. 5 with image from Hong et al., 2010
chrd standard conditions Fig. S11 with image from Xiong et al., 2006
drl standard conditions Fig. 6 with image from Slagle et al., 2011
emx1 standard conditions Fig. 3 with image from Hagos et al., 2007
fgf3 standard conditions Fig. 5 from Ma et al., 2015
Fig. S3 with image from Nechiporuk et al., 2007
fgf8a standard conditions Fig. S3 with image from Nechiporuk et al., 2007
fscn1a standard conditions Fig. 1 with image from Liu et al., 2016
gata2a standard conditions Fig. S11 with image from Xiong et al., 2006
gata6 standard conditions Fig. 5 with image from Hong et al., 2010
gpr137 standard conditions Fig. 5 with image from Hong et al., 2010
gsc standard conditions Fig. 5 with image from Hashiguchi et al., 2008
hnf4a standard conditions Fig. 5 with image from Hong et al., 2010
hoxb1b control Fig. 3Fig. 4 from Ma et al., 2015
chemical treatment by environment: SB 431542 Fig. 4Fig. 6 from Ma et al., 2015
lhx1b standard conditions Fig. 5 with image from Hong et al., 2010
mixl1 standard conditions Fig. 6 with image from Slagle et al., 2011
mxtx1 standard conditions Fig. 5 with image from Hong et al., 2010
ndr1 standard conditions Fig. 6 with image from Hagos et al., 2007
ndr2 standard conditions Fig. 6 with image from Hagos et al., 2007
noto standard conditions Fig. 6 with image from Slagle et al., 2011
Fig. 5 with image from Hashiguchi et al., 2008
otx2b standard conditions Fig. 3Fig. 4Fig. 6 from Ma et al., 2015
Fig. S11 with image from Xiong et al., 2006
chemical treatment by environment: SB 431542 Fig. 4 from Ma et al., 2015
pax2a standard conditions Fig. 6 with image from Slagle et al., 2011
pax6a standard conditions Fig. 3 with image from Hagos et al., 2007
prdm1a standard conditions Fig. 3 with image from Wilm et al., 2005
rasl11b standard conditions Fig. 3 with image from Pézeron et al., 2008
sox2 control Fig. 3 from Ma et al., 2015
sp5a standard conditions Fig. 5 with image from Hong et al., 2010
tbx16 standard conditions Fig. 6 with image from Slagle et al., 2011
tbxta standard conditions Fig. 3 with imageFig. 6 with image from Slagle et al., 2011
tob1a standard conditions Fig. 1 with image from Xiong et al., 2006
wnt8a control Fig. 5 from Ma et al., 2015
krt99 standard conditions Fig. 5 with image from Hong et al., 2010
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab3-smad2/3 control Fig. 4 from Ma et al., 2015
Ab3-smad2/3 chemical treatment by environment: SB 431542 Fig. 4 from Ma et al., 2015
Reporter gene expression No data available
PHENOTYPE
Phenotype in tdgf1tz257/tz257
Phenotype Conditions Figures
dorsal/ventral pattern formation disrupted, abnormal standard conditions Fig. 5 with image from Slagle et al., 2011
Fig. S11 with image from Xiong et al., 2006
embryo development paedomorphic growth, abnormal standard conditions Fig. 1 with image from Xiong et al., 2006
endoderm aplastic, abnormal standard conditions Fig. 6 with image from Pézeron et al., 2008
Fig. 6 with image from Hagos et al., 2007
endoderm endodermal cell decreased amount, abnormal chemical treatment: messenger RNA Fig. 6 with image from Pézeron et al., 2008
epibranchial placode morphology, abnormal standard conditions Fig. 4 with image from Nechiporuk et al., 2007
extension aplastic, abnormal standard conditions Fig. 5 with image from Slagle et al., 2011
eye fused with eye, abnormal standard conditions Fig. 5 with image from Hashiguchi et al., 2008
Fig. 3 with image from Hagos et al., 2007
eye malformed, abnormal standard conditions Fig. 5 with image from Slagle et al., 2011
facial placode morphology, abnormal standard conditions Fig. 4 with image from Nechiporuk et al., 2007
germ ring fscn1a expression absent, abnormal standard conditions Fig. 1 with image from Liu et al., 2016
glossopharyngeal placode morphology, abnormal standard conditions Fig. 4 with image from Nechiporuk et al., 2007
head hypoplastic, abnormal standard conditions Fig. 5 with image from Slagle et al., 2011
head morphology, abnormal standard conditions Fig. 5 with image from Slagle et al., 2011
Fig. S11 with image from Xiong et al., 2006
margin dorsal region fscn1a expression absent, abnormal standard conditions Fig. 1 with image from Liu et al., 2016
mesoderm aplastic, abnormal standard conditions Fig. 6 with image from Hagos et al., 2007
mesoderm morphology, abnormal standard conditions Fig. S3 with image from Nechiporuk et al., 2007
mesoderm development disrupted, abnormal standard conditions Fig. S3 with image from Nechiporuk et al., 2007
neuroectoderm anterior region otx2b expression decreased amount, abnormal control Fig. 3 from Ma et al., 2015
neuroectoderm anterior region sox2 expression decreased amount, abnormal control Fig. 3 from Ma et al., 2015
neuroectoderm anterior region otx2b expression increased distribution, abnormal chemical treatment by environment: SB 431542 Fig. 4 from Ma et al., 2015
neuroectoderm posterior region hoxb1b expression decreased distribution, abnormal control Fig. 3 from Ma et al., 2015
neuroectoderm posterior region hoxb1b expression decreased distribution, abnormal chemical treatment by environment: SB 431542 Fig. 4 from Ma et al., 2015
peripheral nervous system development disrupted, abnormal standard conditions Fig. 4 with image from Nechiporuk et al., 2007
post-vent region malformed, abnormal standard conditions Fig. 5 with image from Slagle et al., 2011
Fig. S11 with image from Xiong et al., 2006
post-vent region structure, abnormal standard conditions Fig. 5 with image from Hashiguchi et al., 2008
rhombomere 4 morphology, abnormal standard conditions Fig. S3 with image from Nechiporuk et al., 2007
rhombomere 4 development disrupted, abnormal standard conditions Fig. S3 with image from Nechiporuk et al., 2007
shield morphology, abnormal standard conditions Fig. 3 with image from Pézeron et al., 2008
whole organism Ab3-smad2/3 labeling decreased amount, abnormal control Fig. 4 from Ma et al., 2015
whole organism Ab3-smad2/3 labeling decreased amount, abnormal chemical treatment by environment: SB 431542 Fig. 4 from Ma et al., 2015
whole organism anterior-posterior axis curved ventral, abnormal standard conditions Fig. 5 with image from Slagle et al., 2011

CITATIONS  (19)